Financial statements Foder Bio-Tech
Balance sheet data of FODER BIO-TECH
Year
|
2021
|
2022
|
---|---|---|
Total assets | 6 327 332,67 | 11 341 330,00 |
A. Fixed assets | 913 715,40 | 3 281 379,38 |
B. Current assets | 5 413 617,27 | 8 059 950,62 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 |
Total liabilities | 6 327 332,67 | 11 341 330,00 |
A. Equity | 402 166,23 | 2 253 125,20 |
B. Liabilities and provisions for liabilities | 5 925 166,44 | 9 088 204,80 |
I. Long-term liabilities | 1 028 812,75 | 1 683 579,38 |
II. Short-term liabilities | 4 896 353,69 | 6 559 467,86 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.